| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Misfits Health Boundary Breaking Snacks 🍫🥣 High protein. Plant-powered. Always tasty. Fuel your appetite for the unconventional. The world's tastiest plant-powered snacks 🍫 🌱 100% Vegan 📈 Protein-packed 😇 Low sugar 🌏 Carbon Neutral Type: | 1 | 0 | 1 | 56 |
 | Newbury Pharmaceuticals AB Your local champion and alternative partner Newbury Pharmaceuticals was founded in 2020 by Swedish Karl Karlsson. We are rapidly growing and offer a product portfolio of specialty pharma medicines with focus on the Scandinavian markets. The portfolio strategy includes niche and value-added small molecules, products based on peptide technology as well as biosimilars in a variety of therapeutic categories. The portfolio consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology representing more than 70 percent. The company was listed on Nasdaq First North, February 2022. Type: | 0 | 0 | 0 | 11 |
 |  Faron A CLEVER Approach to Fight Cancer. Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. Its lead program is bexmarilimab, its investigative precision immunotherapy in Phase I/II development as a novel macrophage checkpoint immunotherapy for patients with hematological malignancies. Bexmarilimab is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Faron is based in Turku, Finland and Boston, Massachusetts. Faron is listed on AIM under the ticker ‘FARN’ and Nasdaq First North Growth Market ("Nasdaq First North") under ticker FARON. Drug discovery, Drug development, Pharmaceuticals, Novel treatments … Type: | 0 | 0 | 0 | 44 |
 | CombiGene CombiGene’s business concept is to develop effective gene therapies for treatment of difficult-to-treat diseases for which adequate treatment methods are currently lacking. The company intends to take its candidate drugs through the phases of preclinical development and initial clinical studies under its own management, and subsequently continue development and commercialization under its own management or in collaboration with other partners. Founded on the basis of scientific discoveries made at Lund University and the University of Copenhagen, CombiGene has offices at Medicon Village in Lund, Sweden. The company is public and listed on the Swedish marketplace Nasdaq First North and the … Type: | 0 | 0 | 0 | 15 |
 | IMIDomics Inc. Discovering and developing the next generation of medicines for immune-mediated inflammatory diseases (IMIDs) IMIDomics is a biotechnology company focused on Patient-Centric drug discovery for immune-mediated inflammatory diseases (IMIDs). Our goal is to discover new and impactful IMID drugs by focusing on carefully selected patients, and stratifying populations to identify those most likely to respond. IMIDomics is powered by a unique Clinical Discovery EngineTM, which integrates and analyzes proprietary clinical, epidemiological and patient-derived biomolecular datasets, generated in partnership with the Vall d’Hebron Institute of Research, to establish a deeper understanding of IMID diseases. By doing so, IMIDomics has identified previously unrecognized … Type: | 2 | 0 | 2 | 23 |
 | GlyProVac Exploring novel bacterial glycopeptide antigens to address unmet needs in vaccine development GlyProVac has via its proprietary platform technology, BEMAP, discovered that 1) O-linked protein glycosylation is a surprisingly abundant post translational modification in bacterial, 2) glycoproteins are linked to increased immunogenicity. GlyProVac aim to be the first to explore and exploit this novel class of antigens as candidates for vaccine development. The GlyProVac lead YghJ/SslE/AcfD is a conserved protein with a known biological function and has vaccine potential not only in ETEC but also in UPEC. Using BEMAP, GlyProVac has identified 59 glycosylated residues in YghJ. We are in … Type: | 0 | 0 | 0 | 11 |
 | HAWK Biosystems Unveiling protein function in patient samples to discovery breakthrough biomarkers. HAWK Biosystems (formerly FASTBASE Solutions) are a biosystems company founded in Bizkaia by Spanish and British scientists from the Francis Crick Institute in London. We have developed a technology that allows for the discovery and quantification of novel biomarkers within any disease state. Specifically, we can determine with high precision which patients will respond to immune-therapy and can stratify patients for treatment using our assay, QF-Pro®. We offer the QF-Pro® service which can be used to discover and quantify biomarkers in FFPE tissue and cell samples and we also offer … Type: | 4 | 0 | 0 | 27 |
 | KLISBio Silk innovation for life sciences KLISBio is a clinical-stage regenerative medicine company. We are developing several innovative technology platforms based entirely on natural silk fibroin, which allow for the creation of various solutions for endogenous tissue repair and regeneration. Silk is one of the most renowned and ancient materials used in medicine. In its raw state, silk consists of two main proteins, sericin and fibroin, with a glue-like layer of sericin coating two singular filaments of fibroin. Silk fibroin is fully biocompatible and promotes cell proliferation by also stimulating in-vivo tissue regeneration. Depending on the technology used, it provides a … Type: | 0 | 0 | 0 | 14 |
 | EnteroBiotix Mastering the microbiome, transforming lives® EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome. Type: | 1 | 0 | 1 | 55 |
 | WIMBA We broke the mold on pet orthotics. We've invented the most advanced, custom-fit, lightest-weight pet orthotics ever — with zero plaster mess involved. Vets can scan, specify, and order WIMBA orthotics right from their smartphones: our Al-powered app scans an animal's limb precisely in just minutes. High-fidelity 3D printing yields durable orthotic devices created exactly to a vet's therapeutic or protective specifications, typically printed within 15 working days and ready for worldwide shipment. Our mission is to help the most pets possible live their best lives with greater mobility. Our team of orthopedic device specialists and veterinary medical experts knew … Type: | 0 | 0 | 0 | 25 |
 | Roumai Medical Next-generation artificial blood vessels Roumai Medical is developing next-generation blood vessels to meet the unmet clincal needs for millions of patients worldwide. Type: | 4 | 1 | 3 | 10 |
 | Sable Bio Empowering Discovery: Precision Insights for Safer Drug Targets. Prevent target safety failures with unique data insights and cutting-edge approaches. Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our advanced workflows assess clinical side effects and predict potential risks for drugs in development using a suite of data modalities. Empower your drug development process with our state-of-the-art solutions. Build trust with industry-leading validation across several proof points. Gain deeper insights into target safety, minimize risks, and optimize assay validation strategies. Type: | 0 | 0 | 0 | 9 |
 | Neurescue Saving Hearts and Minds - Cardiovascular devices to improve outcomes for emergency patients Headquartered in Copenhagen, Denmark, Neurescue delivers cardiovascular devices to improve outcomes for emergency patients. The company is dedicated to Saving Hearts and Minds with the first FDA cleared intelligent balloon system. Medical Technology and Medical Devices Type: | 0 | 0 | 0 | 15 |
 | Autolus Therapeutics Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. Type: | 0 | 0 | 0 | 617 |
 | Desentum Oy Imagine a world without allergies Desentum is a clinical-stage, research-oriented biopharmaceutical company specialized in developing novel types of allergy immunotherapy products (aka allergy vaccines) that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. We have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, we have made discoveries that allow for improved design of vaccines against common types of allergies. Our goal is to provide long-term relief from allergic symptoms with only a few months of treatment, as well as reduce the social and economic burden allergies … Type: | 0 | 0 | 0 | 9 |
 | Oxford Cannabinoid Technologies Holdings Plc A biotech company harnessing the therapeutic power of cannabinoids. Oxford Cannabinoid Holdings Plc is the holding company of Oxford Cannabinoid Technologies Ltd, a UK-based biotech company. We want to have a positive impact on the lives of people living with debilitating diseases and conditions and to change the narrative about cannabis for good. OCT has a range of compounds in drug development, including proprietary cannabinoid derivatives, phytocannabinoids and completely new chemical entities (NCEs) that target the endocannabinoid system. This maximises the therapeutic potential of cannabinoids. With experience across pharmaceutical operations, R&D, intellectual property, law and finance, OCT’s team is committed … Type: | 1 | 0 | 1 | 12 |
 | Orbis Medicines We are developing the future of drug discovery with a platform to discover, develop, and deliver drug candidates for challenging targets. Type: | 0 | 0 | 0 | 17 |
 | AMPLY Discovery Novel Biologics. Designed by Evolution. Discovered by AI. Novel Biologics. Designed by Evolution. Discovered by AI. AMPLY Discovery uses machine learning and synthetic biology to mine vast biological data to discover novel biologic drug and nutraceutical candidates. Using a proprietary in silico and in vitro hybrid platform to discover best-in-class molecules AMPLY is helping tackle some of humankind's greatest challenges such as cancer, MDR infections and metabolic diseases. Based in Belfast, Northern Ireland. Spin out from Queen's University Belfast. Biotechnology, Anti-infectives, Drug Discovery, AI, Machine Learning, Animal Health, Healthcare, Genomics, Metagenomics, Cancer, Biologics, Metabolic Diseases, Natural Drugs, Nutraceuticals, and Bioinformatics Type: | 2 | 0 | 2 | 7 |
 | Curve Therapeutics Revolutionary intracellular screening platform enables a new generation of first-in-class drugs. Our mission is to transform the discovery of first-in-class small molecule therapeutics by broadening the landscape of disease targets that can be drugged. Our Microcycle® platform enables direct screening for biologically active hits inside mammalian cells and creates a toolkit for hit-to-lead programmes. We are deploying our innovative platform to build a pipeline of first-in-class small molecules to address high priority, therapeutically relevant cancer targets. Type: | 2 | 0 | 2 | 30 |
 | Noninvasix Sound Insights Noninvasix will be the first company to monitor the severity of sepsis and septic shock non-invasively, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real time. Incorporating Noninvasix into the ICU workflow allows clinicians to more quickly and accurately diagnose critically ill patients and tailor treatments to improve outcomes. Future developments, enhancements, and evidence will expand our technology's use and clinical impact in other indications and settings. Noninvasix is backed by 15 years of optoacoustic research and more than $6.5 million in research grants. Medical Devices, Optoacoustics, Patient Monitoring, Oximetry, Critical Care, … Type: | 0 | 0 | 0 | 3 |
 | Lantern Pharma Inc. (Nasdaq: LTRN) Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent combinations. Our approach which leverages our RADR … Type: | 1 | 0 | 1 | 27 |
 | GlucoActive Sp. z o.o. A wearable device for non-invasive measurement of blood glucose concentration using spectrophotometric methods. A wearable device for non-invasive measurement of blood glucose concentration using spectrophotometric methods. A device intended for diagnostic, prophylactic purposes, in the process of diabetes treatment and control and for sports applications, diabetes, diabetes care, electronic devices, medical devices, diabetes prevention, diabetes monitoring, diabetes management, medtech, healthcare, and diabetes monitoring Type: | 1 | 0 | 1 | 19 |
 | Sequence Bio Discovering the true signals of disease to power life-changing medicines. 90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that with better, faster drug target discovery powered by the Newfoundland founder effect. Biotechnology and Drug Discovery Type: | 4 | 0 | 3 | 18 |
 | BreatheSuite Helping asthma and COPD patients live longer, healthier lives. Medicare Advantage Plans & ACOs have seen their costs grow in COPD by 53% since 2010, because of high admission and readmission rates (22%). More expensive inhalers are not the only solution to curb this trend. Pulmonary Rehabilitation (PR) is a comprehensive intervention including endurance training, behaviour change and patient education which is proven to significantly improve COPD outcomes. Pulmonary Rehab has been around for decades and recommended by global and national guidelines, but less than 2% of COPD patients get access because there is one PR center for every 43,000 … Type: | 1 | 0 | 1 | 20 |
 | Spangler Candy Company World Class. Family Owned. Spangler Candy is a fourth generation family-owned private company that has been making candy since 1906. Our iconic brands include Dum-Dums®, Bit-O-Honey®, Spangler® Circus Peanuts, Spangler® Candy Canes, Necco Wafers®, Sweethearts®, and Canada® Mints. Spangler is a state-of-the-art manufacturing facility with the latest food production and packaging automation equipment. The company is committed to manufacturing the best quality wholesome product as defined in the guidelines for food safety and food manufacturing regulations established by the United States Food and Drug Administration. We maintain a clean environment, 80% conditioned facility, and excellent working conditions. Spangler places high … Type: | 2 | 0 | 2 | 167 |
 | AGTC Visionary science for life-changing cures. AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's lead product candidates are designed to treat inherited orphan diseases of the eye, caused by mutations in single genes that significantly affect visual function and currently lack effective medical treatments. AGTC's product pipeline includes six named ophthalmology development programs across five targets (X-linked retinoschisis (XLRS), X-linked retinitis pigmentosa (XLRP), achromatopsia, wet age-related macular degeneration and blue cone monochromacy), two non-ophthalmology programs (alpha-1 … Type: | 1 | 1 | 1 | 116 |
 | Geno The Sustainable SourceTM We are accelerating the world's transformation to sustainable materials, by replacing fossil fuel sources with plants. We believe that all products should be responsibly sourced, traceable, and transparent — the sustainable sourceTM. At Geno, we are breaking the planet's reliance on these fossil fuels by creating something better. Our vision to drive climate action at scale starts by making the same molecules, ingredients, and materials we rely on every day, but deriving them from more sustainable sources. Spanning products across a wide variety of industries, Geno’s technologies power high-performance at leading scale and volume, delivering plant-derived ingredients … Type: | 12 | 2 | 11 | 241 |
 | Agenus Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or follow us at @agenus_bio. Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/ Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing Type: | 9 | 2 | 4 | 295 |
 | BioNJ Because Patients Can't Wait® As the largest life sciences association in New Jersey, BioNJ is a powerful network of over 400 Member companies representing research-based life sciences companies and stakeholders. Because Patients Can’t Wait®, we are dedicated to propelling the rich innovation ecosystem in the New Jersey region to stimulate and support innovation, improve and save lives, and lower the hurdles of healthcare advancements for society. As the industry’s voice in New Jersey, we fulfill our mission by ensuring that: Science is Supported Companies are Created Drugs are Developed Patients are Paramount Biotechnology, Pharmaceuticals, Life Sciences, New Jersey, Networking, Advocacy, … Type: | 13 | 3 | 8 | 31 |
 | Children's Advocacy Center of Collin County Providing safety, healing, and justice to children victimized by abuse or neglect in our community. Children’s Advocacy Center of Collin County is a nationally recognized nonprofit organization providing hope to children and families victimized by child abuse. Our proven approach brings experts together under one roof to ensure safety and justice for children. We are the only agency in our community offering services critical to healing, free for life. Therapeutic Counseling, Forensic Interviews, Family Advocacy and Support Services, Medical Evaluations, and Multi-Disciplinary Team Type: | 7 | 1 | 7 | 81 |
 | Stow Kent Animal Hospital, Inc. Quality care in a warm and friendly atmosphere At Stow Kent Animal Hospital Inc., Portage Animal Clinic and Stow Falls Pet Clinic Inc. we strive to provide quality and compassionate care to the community. We see dogs, cats and a variety of exotic companion animals. We are available for routine care to extensive diagnostics along with surgical and dental suites. Utilizing low stress techniques we strive to provide a stress free, positive experience for owners and patients. We have three convenient locations to meet your pet care needs. Our services include- wellness/preventative care, vaccines, nutrition services, senior pet care, microchipping, … Type: | 1 | 1 | 1 | 30 |
 | Array BioPharma Inc. Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC. Small molecule drug discovery and development., oncology, biotechnology, melanoma, and colorectal cancer Type: | 2 | 2 | 0 | 111 |
 | AVEO Oncology Committed to delivering medicines that provide a better life for patients with cancer. AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the … Type: | 1 | 0 | 1 | 196 |
 | Flame Health Associates LLP We are an experienced, specialist, independent medical and healthcare consultancy connecting people and opportunities. Flame Health Associates LLP, is a full-service Independent Medical & Healthcare Consultancy, we provide Executive Search & Selection, Permanent, Interim and Contract Solutions across the UK and Ireland. We have over 150 combined years of experience, coupled with a thorough understanding of how recruitment strategies have evolved over the last twenty years and which direction they will take over the next twenty years. Operating to International Standards, we are a fully compliant Corporate Member of the Recruitment & Confederation (REC) and are committed to its Code … Type: | 0 | 0 | 0 | 22 |
 | Apodis [Automatic translation follows] Connects the players in the medicine sector around the patient #GoodUse #PatientEmpowerment #DrugDisruption #eHealth #AI Apodis is the mobile and web application that connects the players in the medicine sector around the patient to support them in the proper use and compliance with their treatment. Our vision: transforming access to care by allowing patients to become actors in their daily health Apodis addresses two major issues for patients and our health system: - Drug shortages that have been increasing for 20 years - Misuse of drugs that results in more than 1 million days of hospitalization per … Type: | 34 | 7 | 35 | 16 |
 | Biom'up Innovative Biosurgery Founded in 2005 and based in the Lyon suburb of Saint-Priest (France), Biom’up develops and commercializes hemostatic products based on patented biopolymers designed to simplify traditional and laparoscopic surgical procedures in numerous specialties such as cardiac, general and orthopedic, and give patients a better quality of life. The Company’s lead product, HEMOBLASTTM Bellows, is marketed in Europe and the United States. Biotechnologie, Dispositifs Médicaux Implantables, Collagène, Equipements médicaux, Hémostase, Innovative biosurgery, Medical devices, Hemostasis, Collagen, Biotechnology, Pharmacy, Hemoblast, hemostatic, medical devices, and hemostasis Type: | 3 | 1 | 2 | 37 |
 | Eurofins BIO-EC [Automatic translation follows] French laboratory specializing in studies of the efficacy of cosmetic and dermatological products for 24 years 🔬 Since 1998, the BIO-EC Laboratory has specialized in evaluating the efficacy of cosmetic and dermatological products (finished products or active ingredients), but also medical devices and food supplements. Our activity is organized around several areas: 🔸 Ex vivo studies on human skin explants kept alive 🔸 In vivo studies on a panel of healthy volunteers 🔸 Skin absorption studies 🔸 RAMAN spectroscopy studies 🔸 Cosmetogenomics studies All of the studies we carry out are customizable in order to best meet … Type: | 1 | 0 | 1 | 33 |
 | SynapCell We identify your most effective drug candidates in vivo with objective and translational measures within the brain. #EEG SynapCell is a Brain-focused biotechnology company that provides drug developers with robust and unbiased endpoints on drug efficacy in vivo, at the preclinical step. We use quantitative, EEG-based methods to longitudinally monitor a drug effect on translational models, following clinical-like protocols. Our capabilities include dose-response studies, pharmacodynamics, biomarker identification and modulation, disease-modifying assays, model phenotyping, as well as phenotypic screening for lead selection and validation. Our expertise in Neuroscience covers Epilepsy, Parkinson's disease, Essential Tremors as well as information processing defects such … Type: | 10 | 5 | 6 | 40 |
 |  Fluofarma Scientist-to-Scientist Fluofarma, a Porsolt company, joins drug discovery projects to bring tailored solutions in cell biology and high-content analysis. Specialized in assay design, the French preclinical CRO develops and performs cell-based assays and quantifies biomarkers in blood and tissues using different high-content imaging and flow cytometry technologies. Fluofarma's contract research services are based on the following capacities: CUSTOM BIOLOGICAL MODELS > Generation of primary cell cultures, cell lines, 3D spheroids > Development of multi-cell type culture systems in 2D & 3D > Preclinical and clinical samples : whole blood, solid tissues and tissue microarrays (TMAs) ADAPTATION & DEVELOPMENT OF CELL-BASED … Type: | 0 | 0 | 0 | 2 |
 | NORAKER [Automatic translation follows] Bioglass Solutions for Bone Regeneration NORAKER, a French player in regenerative medicine, is dedicated to promoting bone reconstruction for patients who have undergone orthopedic or dental surgery. Spin-off from INSA Lyon in 2005, NORAKER innovates with its mastery of a biomaterial with exceptional properties: bioactive glass. NORAKER has been distributing its implants since 2015, with an international presence in more than 40 countries. The company is committed to close and regular collaboration with surgeons and healthcare professionals to always better meet the requirements of the medical community. NORAKER products are used in orthopedic, spinal, CMF, ENT and … Type: | 21 | 5 | 11 | 43 |
 | AB Science AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science. Our group is specialized in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical needs in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. Our pipeline is both in Human and Veterinary medicine. Our drugs are … Type: | 2 | 1 | 0 | 87 |
 | Nicoya Our mission is to improve human life by helping scientists succeed. Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. Established in 2012, Nicoya was founded by Ryan Denomme in his relentless pursuit to use nanotechnology to increase the affordability and ease of use of scientific instruments. Within 10 years, Nicoya has grown to a team of 100+ employees who have extensive experience working at the forefront of nanotechnology and biotechnology sectors. Nicoya develops innovative and accessible biosensor technology for in-depth characterization of biomolecular interactions. Alto, the world’s first digital high-throughput benchtop SPR instrument, … Type: | 3 | 0 | 3 | 104 |
 | Fuse Vectors Enabling universal access to gene therapy through disruption of manufacturing Viral vector-based gene therapies are the frontier of modern medicine and hold the promise to cure genetic illnesses through single-dose treatments. Manufacturing these complex products is highly challenging and is a major bottleneck of bringing these life-saving therapies to patients. Solving this manufacturing challenge is our core focus. Type: | 0 | 0 | 0 | 11 |
 | Pear Bio Patient-centered cancer precision medicine Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to deconvolute complex cancer biology and drive patient-centric functional precision medicine and drug discovery. Our ultimate goal is to optimally allocate approved treatments to cancer patients who will benefit from them, while creating novel therapies that are purpose-designed for patients who don't respond to available treatments. The platform uses microphysiological systems and 3D computer vision to measure cancer progression over time. Pear Bio cultures patient tumor samples with matched blood into 3D immune-microtumors to test potential treatment options and combinations ex vivo. … Type: | 1 | 1 | 0 | 39 |
 | BioCorteX We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work Type: | 1 | 1 | 0 | 15 |
 | MEDIBIOFARMA SL To make disease-modifying treatments available to patients with serious or life-threatening conditions Medibiofarma S.L is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. We aim to generate innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, IP generation, IBD (Colitis, Crohn), Oncology, CNS, and Synaptopathies Type: | 0 | 0 | 0 | 8 |
 | Modus Therapeutics Holding AB We develop sevuparin to help patients with severe conditions and high unmet medical need. Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition. Sepsis, Systemic inflammation, Heparinoids, Pharmaceutical development, and Pharmaceutical research Type: | 0 | 0 | 0 | 4 |
 | HOOKIPA Pharma Inc. Supercharging Immunotherapy At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV … Type: | 4 | 1 | 3 | 121 |
 | Blackfrog Technologies Design & Manufacture of Emvólio- A portable medical-grade refrigeration system. Blackfrog Technologies Pvt. Ltd. is a Manipal, KA based technology startup company that seeks to improve the efficiency of immunization supply chains. We have developed a patented system for precision cold-chain and vaccine traceability with support from BIRAC (DBT) and leading impact investors in the nation including Venture Centre (NCL, Pune) and Social Alpha to provide logistical support in the last-mile delivery of vaccines. Emvólio is a portable, battery-powered refrigeration device that will strictly maintain any preset temperature for over 12 hours for last mile transport of vaccines. Emvólio’s 2-litre … Type: | 2 | 0 | 2 | 42 |
 | Spring Loaded Technology Getting People Back to Doing More of What They Love At Spring Loaded, we've developed the world's first bracing solution that addresses patellofemoral pain and multi-compartment osteoarthritis. Our Spring Loaded technology absorbs the pressure from the painful joint during knee flexion and transfers those forces to the back of the leg during extension. Immediate relief that is changing OA bracing and improving patient outcomes. Movement Kinematics, Bracing, Medical Device, Knee Pain, Arthritis, Osteoarthritis, Biomechanics, and Springs Type: | 1 | 0 | 1 | 16 |
 | Maya AI Maya AI is a personalized AI solution designed to enhance team performance and improve customer experience. Maya AI is a personalized AI solution designed to enhance team performance and improve the customer care experience. By combining Workflow Automation and Artificial Intelligence, we make tasks easier and faster, with a special focus on personalizing experiences. This empathic approach builds smarter decisions resulting in customer and team retention, satisfaction, and loyalty. With Maya AI, everything feels more personal, boosting engagement and driving success for the future. Unlock a Smarter Approach to Team Dynamics: https://mayaknows.com/ Customer Experience, Scalable, Personalized, HR, Regulation, and Omnichannel Type: | 18 | 1 | 17 | 11 |
 | Inmedical Therapeutics Innovation in medical needs. Inmedical Therapeutics es un fabricante de productos médicos y soluciones en formato hidrogel ubicado en Vitoria. Biotecnología, Endoscopia, Farmacéutica, and Producto Médico Type: | 0 | 0 | 0 | N/A |
 | Koite Health We contribute to a better quality of life with healthcare solutions enabling improved oral health Koite Health is a Finnish health tech company whose innovation, Lumoral®, has already revolutionized dental care in Finland and is quickly expanding in Europe. Lumoral® is an advanced and patented medical device that treats and prevents oral diseases. The company's expert team is composed of high-level professionals with decades of experience in the medical and pharma industries, marketing, and clinical research. The company's scientific board consists of internationally recognized dental professors and researchers. Lumoral is an oral health device used in addition to regular tooth … Type: | 0 | 0 | 0 | 20 |
 | Isomab Ltd IsomAb is taking a different approach to identify, evaluate and develop isoform specific antibodies to treat disease where patients currently have limited or no treatment options. IsomAb is developing isoform specific antibodies and it has identified, using a combined bioinformatics/knowledge-based platform approach, ISM-001 which specifically inhibits the VEGF-A165b isoform of Vascular Endothelial Growth Factor-A (VEGF-A); based on 20 years of research by our two Founders, the evidence shows reducing serum levels of VEGF-A165b is key to ensuring new blood vessel formation in patients with ischemic disease. Type: | 0 | 0 | 0 | 13 |
 | TruSpine Technologies plc Preserving Natures Design TRUSPINE TECHNOLOGIES LIMITED is a medical device company focused on developing uniquely disruptive technologies to revolutionise the spinal stabilisation market, commencing with three flagship pioneering devices. The Cervi-LOKTM (for the cervical and upper thoracic spine), GRASP Laminoplasty (a treatment for decompression of the spinal cord) & Faci-LOKTM (for the lumbar and lower thoracic spine). These unique devices represent a paradigm shift in spinal fixation, by providing exceptional stabilisation while not altering the bony anatomy unlike screws, staples or other devices which currently dominate the spinal market. Medical Devices, Medical research, Orthopedics, and Spinal stabilisation Type: | 0 | 0 | 0 | 4 |
 | Argá Medtech SA Redefining Cardiac Ablation, Coherent Sine-burst electroporation (CSE), innovation, pulsed field ablation (PFA) Argá Medtech SA is a privately-held medical device company based in Switzerland founded by seasoned team of leaders in the industry. Argá is developing an innovative non-thermal energy based cardiac ablation system for the treatment of cardiac arrhythmias. With the use of Pulsed Electrical Fields (PEF) to create irreversible electroporation (IRE) of cardiomyocytes, Argá is developing a safer, faster, cheaper and more effective cardiac ablation treatment for the benefit of millions of people affected by cardiac rhythm disorders and atrial fibrillation. cardiology, cardiac ablation, PFA, IRE, PEF, electro … Type: | 1 | 0 | 1 | 17 |
 | adsilico Limited Redefining medical device innovation with virtual populations and in silico trials. Redefining medical device innovation Type: | 0 | 0 | 0 | 10 |
 | ForaCare Inc. Pioneers in remote patient monitoring ForaCare was established by Dr. Sophia Wu in 2007 with the main function of marketing and sales of high-quality medical devices. Our mission is to complete the cycle of chronic disease management by combining innovative technologies with accurate medical devices. As the new leader in medical device technology, we specialize in diabetes and hypertension. We offer a best-in-class, worldwide medical device quality management system that enables our company to meet stringent quality and process controls. We have numerous certificates including ISO 9001:2008, ISO 13485:2003, GMP and CE. Additionally, our server which hosts our advanced TeleHealth … Type: | 0 | 0 | 0 | 46 |
 | CPC - Colder Products Company We Inspire Confidence at Every Point of Connection CPC is the leading provider of quick disconnect couplings, fittings and connectors for life sciences, specialty industrial and chemical handling markets. Used in a broad range of applications, our innovative coupling and connection technologies allow flexible tubing to be quickly and safely connected and disconnected. CPC makes people’s lives better by developing innovative high quality products that make fluid handling safe and easy. CPC’s products are used across a broad range of medical devices and equipment, including surgical, dialysis, blood pressure monitoring, patient therapy devices, and in vitro diagnostics. A de facto … Type: | 0 | 0 | 0 | 419 |
 | Charter Medical Single-use technologies for the cell therapy, bioprocessing, and biotechnology industries. Lifechanging breakthroughs like cell and gene therapy are driving a medical revolution. But a lack of purpose-built development and manufacturing tools keeps these treatments from reaching more patients. At Charter Medical, we’re on a mission to evolve single-use cell processing step-by-step with the needs of the biopharmaceutical innovators who count on us. With proven customization capabilities and an innovation roadmap that includes pioneering design and biomaterials. With industry-leading expertise and continuous improvement to simplify and standardize biomanufacturing systems so they can scale reliably. And with a deep commitment to responsiveness, … Type: | 0 | 0 | 0 | 87 |
 | Ionis Pharmaceuticals, Inc. For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. RNA-targeted medicines and RNA-targeted therapeutics Type: | 1 | 0 | 0 | 1,093 |
 | Medical Alley Medical Alley is the epicenter of health innovation and care®. Medical Alley represents a network of more than 800 healthcare industry organizations working together to change healthcare for the better. Our mission: Activate and amplify healthcare transformation. Medical Alley creates context, connections, and collaborations that elevate the healthcare industry. Our current key initiatives include: Enabling healthcare innovation, elevating business progress, and transforming health equity. Listen to the Medical Alley Podcast at www.medicalalleypodcast.org to hear weekly conversations with healthcare and medtech leaders who are helping make Medical Alley the epicenter of health innovation and care. medical device, pharmaceutical, biopharmaceutical, diagnostics, health … Type: | 19 | 0 | 18 | 39 |
 | Lumetrics®, Inc. Revolutionizing Non-Contact Measurements for your Infrared Products. Lumetrics develops and manufactures non-contact thickness measurement and optical inspection systems for medical, glass, food packaging, ophthalmic, automotive, silicon wafer, and film industries. Our breakthrough precision thickness measurement technology is fast, accurate, flexible, and scalable to most QA laboratories, R&D centers, or production lines. With our personalized service, every client benefits from direct collaboration with our engineers. Lumetrics provides off-the-shelf products as well as custom metrology solutions specifically built to meet your needs. Since 2003, Rochester, N.Y.-based Lumetrics has been developing and manufacturing high-precision thickness measurement and gauging systems for a growing cross-section … Type: | 2 | 0 | 2 | 26 |
 | Society for Reproductive Investigation Transforming lives through excellence in reproductive health sciences. A premier scientific organization in obstetrics and gynecology, the Society for Reproductive Investigation (SRI) now has almost 1,000 members throughout the world. One-third are basic scientists and two-thirds are clinical investigators. SRI members conduct basic, translational, and clinical investigation in the reproductive sciences and women’s health. Areas of focus include obstetrics, perinatology, reproductive genetics, gynecology and gynecologic oncology, endocrinology, reproductive physiology, biochemistry, pharmacology, immunology, epidemiology, reproductive infectious disease, and reproductive, stem cell, and developmental biology. Many members hold NIH grants or their international equivalents and/or serve on study sections and advisory councils … Type: | 1 | 1 | 0 | 4 |
 | NanoString Technologies, Inc. Mapping the universe of biology 🧬 NanoString Technologies, a Bruker Company, is a provider of life science tools for translational research. The company's technology enables a wide variety of basic research and translational medicine applications. NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression … Type: | 10 | 2 | 7 | 524 |
 | Ginkgo Bioworks, Inc. Making biology easier to engineer. At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our … Type: | 15 | 9 | 1 | 1,130 |
 | Detox of South Florida - Best Rehab and Detox Center We focus primarily on addiction treatment, which includes detoxification and rehabilitation for drugs and alcohol. We provide world class care and treatment services. You’ll always feel at home in the entire duration of your stay at Detox of South Florida. We only work with professional medical experts who are knowledgeable in addiction treatment and rehabilitation. Our staff is fully committed to provide you with the best care and service. If you’d like to know more about our treatment services or want to verify your insurance, feel free to contact us today and talk to one of our friendly professionals. We … Type: | 2 | 0 | 1 | 9 |
 | BioSurfaces, LLC Nanomaterial Solutions BioSurfaces, based in Ashland, Massachusetts, is a life science company with deep leadership and a diverse team of specialists. The company’s proprietary electrospinning technology known as Bio-SpunTM creates product solutions by engineering biology with synthetic cellular matrices for applications ranging from IVRT and delivery of bio-active therapeutics to medical devices and consumer health products. These materials can be made to form a variety of unusual and difficult-to-manufacture shapes while also demonstrating improved biocompatibility over other textile-based materials. The BioSurfaces manufacturing process also allows the incorporation of drugs or other bioactive agents directly into the nanofibers for localized release. … Type: | 1 | 1 | 1 | 12 |
 | Debiopharm we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university … Type: | 14 | 5 | 10 | 502 |
 | Asklepios BioPharmaceutical, Inc. (AskBio) Pioneering science to create transformative molecular medicines. Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, Huntington’s disease, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10TM, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter … Type: | 5 | 2 | 1 | 507 |
 | Shuimu BioSciences Cryo-EM & AI Powered Drug Discovery Powerhouse. Shuimu is a rapidly evolving global cryo-EM & AI platform for early drug discovery, founded in 2017 and headquartered in Beijing, China. Shuimu drives innovation to accelerate the development of innovative drugs. Shuimu leverages the power of cutting-edge cryo-EM & AI technology to help its partners gain key structural insights into the target proteins and complexes. The team consists of top talents with global backgrounds in the field of structural biology, machine learning, protein science, and drug chemistry. Learn more about Shuimu and check out its cryo-EM precision imaging platform by visiting shuimubio.com … Type: | 0 | 0 | 0 | 25 |
 | PetMedix R&D stage veterinary therapeutics biotechnology company based in Cambridge, UK The PetMedix channel will soon be discontinued as we join forces with Zoetis. Follow the Zoetis channels to stay connected and for the latest updates! Biotechnology, Drug Development, Drug Discovery, Therapeutic Antibodies, Monoclonal Antibodies, Companion Animal, Veterinary Medicine, and Research and Development Type: | 8 | 0 | 7 | 16 |
 | NANOVERY Nanovery - experts in nucleic acid quantification using DNA nanorobots. We developed a proprietary Nucleic Acid Nanorobotics (NANs) platform that simplifies molecular testing and quantification for RNA therapeutics and biomarkers. Type: | 0 | 0 | 0 | 14 |
 | Mosanna Therapeutics A Swiss Biotech company with a commitment to improving patient outcomes and quality of life in high unmet need diseases Mosanna is a Swiss Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. We carefully select innovative medicines for further development using the best contract research organisations in the specific specialised field. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients. Type: | 0 | 0 | 0 | 7 |
 | Vitarka Therapeutics Curing the untreated: Vitarka Therapeutics is a pre-clinical biotech company determined to combat late-stage cancers. Type: | 1 | 0 | 1 | 6 |
 | ASTRA Therapeutics Precision Drugs against Eucaryotic Pathogens ASTRA Therapeutics is a Drug Discovery company with a mission to design and develop novel, precision engineered drugs against a whole range of Eukaryotic Pathogens. Type: | 1 | 0 | 0 | 3 |
 | Invitris A startup using Synthetic Biology to innovate the way we develop entirely novel classes of protein-based drugs. Our patent-pending biotech platform, Phactory, makes designing synthetic proteins 10,000x more effiicent and reduces the material costs by 100x. We are leveraging Phactory to develop the newest classes of protein-based drugs, such as the next generation of antibiotics. Type: | 0 | 0 | 0 | 18 |
 | Beckley Psytech Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions. Beckley Psytech is a private, clinical-stage biotechnology company dedicated to improving the lives of people suffering from neuropsychiatric disorders by transforming psychedelics into effective and rapid-acting medicines. Our vision is for clinically validated psychedelic medicines to be integrated into modern medical practice in order to help patients living with depression and other profoundly debilitating neuropsychiatric conditions with a high unmet need. Founded in 2019, and underpinned by more than two decades of pioneering scientific research from the Beckley Foundation, we combine world-leading psychedelic science with deep neuropsychiatric drug development expertise … Type: | 5 | 1 | 4 | 63 |
 | Cellestia Biotech Cellestia Biotech is pioneering innovative therapeutics based on novel modes of action to treat autoimmune diseases and multi-drug resistant cancers. Our clinical stage drug candidate, CB-103, has demonstrated both safety and biological activity in humans. Along with ongoing Phase 2 IITs for multi-drug resistant cancers, CB-103 is also poised to enter a Proof-of-Concept clinical study for graft-versus-host disease (GvHD) Biopharma, Oncology, Precision Medicine, Small Molecules, Targeted Therapy, Biotech, Cancer Therapy, Transcription Factors, Autoimmune Disorders, and Inflammatory Disorders Type: | 3 | 0 | 0 | 15 |
 | Reliefband Technologies LLC The Anti-Nausea Wristband helping you overcome life's uncomfortable moments. Reliefband® is a world leader in neuromodulation creating the first FDA-cleared, clinically proven wearable device that treats nausea and vomiting associated with sea sickness, motion sickness, migraines, anxiety, and more. Worn on the wrist, Reliefband's patented technology stimulates a nerve that sends a message to the brain to "turn off" nausea, providing quick and effective relief without any unwanted side effects. Type: | 1 | 0 | 1 | 8 |
 | Lactation Lab We make food labels for your breastmilk. We make food labels for your breast milk. Founded by a doctor and mother-of-two, Lactation Lab analyzes your breast milk for basic nutritional content like calories and protein, as well as vitamins, fatty acids and environmental toxins. Results are delivered in a user-friendly report that reads like a food label. We explain how your results affect your child, offer suggestions for enhancing the quality of your milk and provide the option for personal consultation. Insights, resources and support. We believe that knowledge leads to confidence and that confidence leads to empowerment. By offering … Type: | 1 | 0 | 1 | 7 |
 |  AveXis, Inc. AveXis is now Novartis Gene Therapies Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal muscular atrophy (SMA). Follow us on LinkedIn: https://www.linkedin.com/company/novartis-gene-therapies/ How to reach us: Novartis Gene Therapies 2275 Half Day Road, Suite 200 Bannockburn, IL 60015 Email: gtx.communications@novartis.com Office Phone: 847.572.8280 Toll-free Phone: 844.428.3947 Gene Therapy, Synthetic Biology, and Spinal Muscular Atrophy Type: | 1 | 0 | 0 | 107 |
 | Cell-Free Technology Ltd. We build biocomputers. We are hiring. Type: | 1 | 0 | 0 | 0 |
 | BRAINCURES Powering a drug discovery revolution to deliver cures for brain diseases that affect at least 1 in 10 people worldwide Brain diseases have no cures and affect 1 in 10 people worldwide and their families. BRAINCURES aims to tackle brain diseases with precision medicine based on the code for brain function. Our landmark decoding of the molecular framework behind brain health pinpointed SMART Target-Biology linkages that now empower novel translational avenues to conquer brain diseases through SMART Patient Stratification and SMART Treatments. The application of our proprietary platform technologies will lead to personalized treatments for the 350 million people worldwide … Type: | 1 | 0 | 1 | 2 |
 | Yuri Space biotech for a better life 🧫🚀 yuri is a space biotech company that uses the microgravity environment of space to develop and manufacture superior biotech products. The team of 30+ space engineers and biologists has worked on 20+ payloads for the International Space Station in collaboration with organizations like NASA, ESA, GSK, Charité Berlin. We develop modular bioreactors and incubators for cell cultures, protein crystals or plants and launch them for scientists around the world to the ISS and other spacecraft such as Sierra Nevada Dream Chaser or SpaceX Dragon. We also sell and rent devices to simulate microgravity … Type: | 17 | 2 | 16 | 50 |
 | VoltSafe Inc. A safer, simpler and smarter way to connect and control electricity. unplug. connect. At VoltSafe, we're fearless creators, obsessed with progress. Our products are unique and our technology is revolutionary in the field of electronics. And while everyone is infatuated with innovations at one end of the power cord, we’re obsessed with improving the other end to change how people connect to power. Simply put, we’ve discovered a smarter and safer way to connect to electricity using magnets. Importantly, our patented technology empowers retail producers, industries, governments and essential services to do their jobs more safely, efficiently and sustainably. Our … Type: | 1 | 0 | 1 | 21 |
 | Virtue Health Virtue is a digital therapeutics company developing new approaches to treat and prevent age-related diseases. health and health tech Type: | 3 | 3 | 0 | 1 |
 | Ventec Life Systems Defining Integrated Respiratory Care Ventec Life Systems was recently acquired by React Health. For up to date information, please visit the React Health Linkedin Page. medical devices, life-support ventilators, ventilation, and portable ventilator Type: | 1 | 1 | 1 | 270 |
 | TORSKAL 🌿 Green nanoparticles for cancer therapy TORSKAL is an international biotech/medtech company, a pioneer of green nanotechnology. We design disruptive gold nanoparticles for cancer therapy from green chemistry. We are committed to the development of a new generation of non-toxic and eco-friendly nanomaterials for the treatment of surface and deep cancers by green chemistry. We have discovered an innovative, green, and patented way of producing gold nanoparticles, leveraging Indian Ocean endemic plants, that have many applications in health. Our first and main project, the Nanotheranostics Project (NT1), a treatment for skin cancer using near-infrared (IR) radiation-induced plasmonic phototherapy is entering … Type: | 11 | 4 | 9 | 3 |
 | CONNECTA Therapeutics Promoting neuroplasticity modulation. CONNECTA Therapeutics S.L. is a biotechnology company that develops new treatments for CNS unmet medical needs. The company is initially focus on the clinical development of a new “first-in-class” molecule for the treatment of fragile X syndrome (FXS). FXS is the most common cause of hereditary intellectual disability and there are no therapeutic interventions currently available. The molecule was discovered after evaluating more than 30 molecular and cellular targets. The molecule has been proven, in in vitro tests and in vivo in animal models, to be an excellent neuroplasticity modulator with a great extension profile for other … Type: | 0 | 0 | 0 | 7 |
 | coIMMUNE, Inc. coIMMUNE is a privately held, clinical stage immune-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a novel CAR therapy that promises enhanced efficacy with greatly reduced toxicity. Type: | 5 | 2 | 3 | 8 |
 | ILC Therapeutics ILC Therapeutics is a specialist UK-based developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles, enabling broad applications across multiple indications. Hybrid interferons combine favourable attributes of specific natural interferon sub-types to produce novel drug candidates designed to deliver reduced toxicity and improved efficacy. ILC Therapeutic’s platform approach has produced two first-in-class lead candidates, AlfacyteTM and DermacyteTM focused on antiviral and dermatological indications respectively, which are progressing towards the clinic. Type: | 0 | 0 | 0 | 7 |
 | MucoLife Therapeutics We develop novel mucolytic drugs to transform the treatment landscape of COPD and other lung diseases. We develop novel mucolytic drugs to transform the treatment landscape of COPD and other lung diseases. COPD and Mucus Type: | 0 | 0 | 0 | 2 |
 | Mestag Therapeutics New therapies for cancer and inflammatory disease targeting fibroblast-immune interactions Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we are advancing a pipeline of first-in-class tailored antibody programs and targets for new treatments. Backed by committed leading global investors, world-class founders and a highly experienced leadership team, Mestag offers an exciting, diverse and balanced place to work, with competitive benefits, generous vacation time and the room to grow and develop your career. biotechnology, fibroblasts, oncology, immuno oncology, inflammatory disease, and datascience Type: | 0 | 0 | 0 | 52 |
 | Epitopea Exploiting a new class of tumour specific antigens for cancer therapy A newly established NewCo developing therapeutics targeting a novel class of tumour-specific antigen. TCR-T cells, Immuno-oncology, Vaccines, Bi-specifics, Splicing, Epigenetics, Oncology, T cell biology, and Antigen presentation Type: | 2 | 0 | 2 | 16 |
 | HEDERA-22 Intelligent Natural Product Discovery Platform. Hedera-22 is dedicated to unveiling novel natural products to address critical gaps in agriculture markets. Our focus involves creating an advanced natural product discovery platform, utilizing DNA-based synthesis and exclusive predictive bioinformatics. This innovative approach streamlines discovery, enhancing output, diversity, and compound maturity. Our extensive molecule library is open for screening, inviting opportunities for licensing or partnerships. Committed to contributing to a sustainable planet, our goal is to develop environmentally friendly products for crop protection, fostering a greener and more resilient future. Next Generation Biomolecules, Predictive approaches, Synthetic biology, Bio-informatics, Natural Products Discovery, AI, and … Type: | 1 | 0 | 0 | 10 |
 | HAYA Therapeutics Inspired to Transform, The Genome Informs - RNA-Guided Therapeutics to Target Disease Causing Cell-States HAYA Therapeutics is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disease and cancer. The company is using its innovative cell-state modifying platform to gain novel insights into the biology of long non-coding RNAs (lncRNAs), the ‘dark genomes’ information processing features and ‘source code’. HAYA’s lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting Wisper, which is a tissue and cell-specific cardiac lncRNA known to play a role in heart failure. The company is also developing … Type: | 3 | 2 | 0 | 47 |
 | Uman Sense We have developed Stroke Alarm — a wearable aid for patients with elevated stroke risk. Our product: Stroke is the most common cause of permanent disability in adults, and the second most common cause of death in the Western world. Today, people who suffer a stroke can be cured if they receive the right treatment in time. Unfortunately, most arrive too late. We hope to change that with Stroke Alarm — a wearable aid for patients with elevated stroke risk. Do you manage patients with increased risk of suffering a stroke? Right now, we offer the Swedish healthcare the opportunity … Type: | 0 | 0 | 0 | 9 |
 | ABANZA Providing surgeons with the innovation to regain patients' quality of life. ABANZA specializes in the Development & Research of Innovative Medical Devices in the field of Sports Medicine - Soft Tissue repair. With the goal of offering cutting edge surgical tools, ABANZA is supported by a first class medical advisory team in order to ensure that the devices developed are safe and easy to handle, thereby offering surgeons the utmost reliability and ensuring that patients receive the best possible care. Healthcare, Medical supplies, Medical devices, and Biotechnology Type: | 0 | 0 | 0 | 28 |
 | Selvita Integrated Drug Discovery | Drug Development | Contract Research Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening Type: | 4 | 0 | 2 | 723 |
Startup